BioXconomy has reported on the sustainability issues in peptide manufacturing and how the immense scale of GLP-1 demand has forced the industry to consider alternatives to forever chemicals. Right now, I think we had a little bit of a bad rap on the PMI [process mass intensity], Kopach said, referring to one of the primary metrics for evaluating total raw material usage in drug production
More Gradual Results Ozempic face, or a hollowed-looking face as a result of taking GLP-1s, is a major concern for many people
The lactate sensor GPR81 regulates glycolysis and tumor growth of breast cancer
Using the right type can make a big difference in managing constipation safely
Consider whether to continue, modify, or begin transitioning to maintenance
What are the approved alternatives to retatrutide for weight management in the UK